Mitchel Sayare - Net Worth and Insider Trading
Mitchel Sayare Net Worth
The estimated net worth of Mitchel Sayare is at least $12 Million dollars as of 2024-11-10. Mitchel Sayare is the Director of Immunogen Inc and owns about 383,136 shares of Immunogen Inc (IMGN) stock worth over $12 Million. Mitchel Sayare is also the Director of Altimmune Inc and owns about 1,088 shares of Altimmune Inc (ALT) stock worth over $8,356. Details can be seen in Mitchel Sayare's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mitchel Sayare has not made any transactions after 2017-12-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mitchel Sayare
Mitchel Sayare Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mitchel Sayare owns 2 companies in total, including Altimmune Inc (ALT) , and Immunogen Inc (IMGN) .
Click here to see the complete history of Mitchel Sayare’s form 4 insider trades.
Insider Ownership Summary of Mitchel Sayare
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALT | Altimmune Inc | 2020-06-25 | director |
| IMGN | Immunogen Inc | 2011-07-29 | director & Chief Executive Officer |
Mitchel Sayare Latest Holdings Summary
Mitchel Sayare currently owns a total of 2 stocks. Among these stocks, Mitchel Sayare owns 383,136 shares of Immunogen Inc (IMGN) as of July 29, 2011, with a value of $12 Million and a weighting of 99.93%. Mitchel Sayare also owns 1,088 shares of Altimmune Inc (ALT) as of December 29, 2017, with a value of $8,356 and a weighting of 0.07%.
Latest Holdings of Mitchel Sayare
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMGN | Immunogen Inc | 2011-07-29 | 383,136 | 31.23 | 11,965,337 |
| ALT | Altimmune Inc | 2017-12-29 | 1,088 | 7.68 | 8,356 |
Holding Weightings of Mitchel Sayare
Mitchel Sayare Form 4 Trading Tracker
According to the SEC Form 4 filings, Mitchel Sayare has made a total of 0 transactions in Immunogen Inc (IMGN) over the past 5 years. The most-recent trade in Immunogen Inc is the sale of 10,000 shares on July 29, 2011, which brought Mitchel Sayare around $132,500.
According to the SEC Form 4 filings, Mitchel Sayare has made a total of 0 transactions in Altimmune Inc (ALT) over the past 5 years. The most-recent trade in Altimmune Inc is the acquisition of 170 shares on December 29, 2017, which cost Mitchel Sayare around $9,945.
Insider Trading History of Mitchel Sayare
- 1
Mitchel Sayare Trading Performance
GuruFocus tracks the stock performance after each of Mitchel Sayare's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mitchel Sayare is -12.55%. GuruFocus also compares Mitchel Sayare's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mitchel Sayare within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mitchel Sayare's insider trading performs compared to the benchmark.
Performance of Mitchel Sayare
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.63 | | | | | |
| Relative Return to S&P 500(%) | -3.04 | | | | | |
Mitchel Sayare Ownership Network
Ownership Network List of Mitchel Sayare
Ownership Network Relation of Mitchel Sayare
Mitchel Sayare Owned Company Details
What does Altimmune Inc do?
Who are the key executives at Altimmune Inc?
Mitchel Sayare is the director of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .
Altimmune Inc (ALT) Insider Trades Summary
Over the past 18 months, Mitchel Sayare made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net sale of 15,711 shares made by David Drutz ,
In summary, during the past 3 months, insiders sold 16,011 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 16,011 shares. During the past 18 months, 16,011 shares of Altimmune Inc (ALT) were sold and 300 shares were bought by its insiders, resulting in a net sale of 15,711 shares.
Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Altimmune Inc Insider Transactions
Mitchel Sayare Mailing Address
Above is the net worth, insider trading, and ownership report for Mitchel Sayare. You might contact Mitchel Sayare via mailing address: 128 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
